Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LISA PITINO

Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation Pain Medicine

NPI
1245415280
CMS profile
996833
Location
LAGUNA HILLS, CA

General Payments · PY2018–2024

$4,541.70

  • Reported across 176 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$703.27

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $703.27 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
FORTE BIO-PHARMA LLC $191.29 10
Collegium Pharmaceutical, Inc. $188.67 9
ABBVIE INC. $117.30 5
Curonix LLC $62.48 3
PFIZER INC. $39.16 2
Averitas Pharma Inc. $38.57 1
SCILEX PHARMACEUTICALS INC. $23.33 1
GlaxoSmithKline, LLC. $17.94 1
Abbott Laboratories $13.32 1
SPR Therapeutics, Inc $11.21 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $230.75 10
PY2019 $1,030.37 22
PY2020 $463.55 16
PY2021 $444.12 17
PY2022 $712.29 18
PY2023 $957.35 58
PY2024 $703.27 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $13.32 02/28/2024 Food and Beverage Undisputed 01/23/2026 1124919151 CMS
ABBVIE INC. $24.86 01/02/2024 Food and Beverage Undisputed 01/23/2026 1105276199 CMS
ABBVIE INC. $20.08 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105276203 CMS
ABBVIE INC. $18.57 03/01/2024 Food and Beverage Undisputed 01/23/2026 1105276207 CMS
ABBVIE INC. $23.04 04/25/2024 Food and Beverage Undisputed 01/23/2026 1105276211 CMS
ABBVIE INC. $30.75 07/08/2024 Food and Beverage Undisputed 01/23/2026 1105276216 CMS
Averitas Pharma Inc. $38.57 02/22/2024 Food and Beverage Undisputed 01/23/2026 1133441551 CMS
Collegium Pharmaceutical, Inc. $19.65 01/04/2024 Food and Beverage Undisputed 01/23/2026 1135202323 CMS
Collegium Pharmaceutical, Inc. $19.26 01/16/2024 Food and Beverage Undisputed 01/23/2026 1135206178 CMS
Collegium Pharmaceutical, Inc. $24.32 03/18/2024 Food and Beverage Undisputed 01/23/2026 1135229082 CMS
Collegium Pharmaceutical, Inc. $6.60 04/09/2024 Food and Beverage Undisputed 01/23/2026 1135238572 CMS
Collegium Pharmaceutical, Inc. $24.11 04/15/2024 Food and Beverage Undisputed 01/23/2026 1135240951 CMS
Collegium Pharmaceutical, Inc. $22.83 06/25/2024 Food and Beverage Undisputed 01/23/2026 1135269274 CMS
Collegium Pharmaceutical, Inc. $24.93 07/29/2024 Food and Beverage Undisputed 01/23/2026 1135281873 CMS
Collegium Pharmaceutical, Inc. $22.85 08/28/2024 Food and Beverage Undisputed 01/23/2026 1135294384 CMS
Collegium Pharmaceutical, Inc. $24.12 11/12/2024 Food and Beverage Undisputed 01/23/2026 1135324080 CMS
Curonix LLC $17.88 02/20/2024 Food and Beverage Undisputed 01/23/2026 1132911631 CMS
Curonix LLC $24.65 06/21/2024 Food and Beverage Undisputed 01/23/2026 1132911633 CMS
Curonix LLC $19.95 07/15/2024 Food and Beverage Undisputed 01/23/2026 1132911635 CMS
Forte Bio-Pharma LLC $31.27 06/17/2024 Food and Beverage Undisputed 01/23/2026 1142419944 CMS
Forte Bio-Pharma LLC $9.73 06/25/2024 Food and Beverage Undisputed 01/23/2026 1142419946 CMS
Forte Bio-Pharma LLC $12.43 07/03/2024 Food and Beverage Undisputed 01/23/2026 1142419948 CMS
Forte Bio-Pharma LLC $10.09 08/01/2024 Food and Beverage Undisputed 01/23/2026 1142419950 CMS
Forte Bio-Pharma LLC $9.04 09/05/2024 Food and Beverage Undisputed 01/23/2026 1142419952 CMS
Forte Bio-Pharma LLC $28.57 09/12/2024 Food and Beverage Undisputed 01/23/2026 1142419954 CMS
Forte Bio-Pharma LLC $29.16 10/08/2024 Food and Beverage Undisputed 01/23/2026 1142419956 CMS
Forte Bio-Pharma LLC $8.16 11/04/2024 Food and Beverage Undisputed 01/23/2026 1142419958 CMS
Forte Bio-Pharma LLC $22.67 11/27/2024 Food and Beverage Undisputed 01/23/2026 1142419960 CMS
Forte Bio-Pharma LLC $30.17 12/04/2024 Food and Beverage Undisputed 01/23/2026 1142419962 CMS
GlaxoSmithKline, LLC. $17.94 08/01/2024 Food and Beverage Undisputed 01/23/2026 1115915031 CMS
PFIZER INC. $17.24 03/06/2024 Food and Beverage Undisputed 01/23/2026 1131134961 CMS
PFIZER INC. $21.92 12/19/2024 Food and Beverage Undisputed 01/23/2026 1131417611 CMS
SCILEX PHARMACEUTICALS INC. $23.33 09/10/2024 Food and Beverage Undisputed 01/23/2026 1136270285 CMS
SPR Therapeutics, Inc $9.49 09/30/2024 Food and Beverage Undisputed 01/23/2026 1104942007 CMS
SPR Therapeutics, Inc $1.72 09/30/2024 Food and Beverage Undisputed 01/23/2026 1104942011 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.